Dr. Stuart Wong points out the control arm performed favorably compared to EORTC 22931 and RTOG 9501 studies. Several key questions remain unanswered. #ASCO25

Live from #ASCO25! I'm taking over the @ascocancer.bsky.social account. Join us in S100bc for “AI, Improving Cancer Care, and the Future of Collaboration” featuring @googlecloud CEO Thomas Kurian & ASCO CEO Dr. @CliffordHudis at 4:30 PM

THIRD! Dr. Andrew Kuykendall presents VERIFY: rusfertide vs placebo for polycythemia vera. During weeks 20-32, more patients who received rusfertide achieved a clinical response, 76.9 vs 32.9%, p<0.0001. Patients received fewer phlebotomies and had less fatigue. #ASCO25

Don’t forget to stop by our booth! Learn more about our memberships, upcoming meetings, and all the ways we support the oncology community. Whether you're a longtime member or just getting to know us, we’d love to connect with you! #ASCO25

I am hosting a takeover for @ascocancer.bsky.social about “AI, Improving Cancer Care, and the Future of Collaboration" with Google Cloud CEO Thomas Kurian and ASCO CEO Dr. Clifford Hudis. See you here and at S100bc at 4:30 PM

#Oncology #GlobOnc #ClinicaPharmacology #oncologia

I am honored to be a #ASCO25 Featured Voice! I will amplify trainee posts and research on #DrugDevelopment, #SurvOnc and global oncology.
📢 Hosting a Takeover for
@ascocancer.bsky.social bout “AI and Cancer Care” on June 1 at 4:30 PM

#Oncology #GlobOnc #ClinicaPharmacology #oncologia